UK markets open in 45 minutes
NIKKEI 225
37,926.80 +298.32 (+0.79%) HANG SENG
17,720.97 +436.43 (+2.53%) CRUDE OIL
84.03 +0.46 (+0.55%) GOLD FUTURES
2,352.70 +10.20 (+0.44%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,547.05 +143.27 (+0.28%)
Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.5700 |
| Open | 3.5000 |
| Bid | 3.2400 x 200 |
| Ask | 3.3100 x 200 |
| Day's range | 3.2300 - 3.5000 |
| 52-week range | 3.2300 - 37.9800 |
| Volume | |
| Avg. volume | 1,830,946 |
| Market cap | 342.871M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.8300 |
| Earnings date | 06 May 2024 - 21 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 14.91 |
- Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
NASHVILLE, Tenn., April 12, 2024--Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Simply Wall St.Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Key Insights Institutions' substantial holdings in Revance Therapeutics implies that they have significant influence...
- Business Wire
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NASHVILLE, Tenn., March 27, 2024--Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
© 2024 Yahoo. All rights reserved.